Liquidia Corp

LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819576

Price chart

Open-market purchases and sales by LQDA insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 15, 20264:30 PM ETSep 11 – Sep 14, 2026SINGH RAMANDirectorSSaleCommon Stock−17.49K$67.4281−$1.18M44.64K−28.2%SEC
Sep 3, 20264:30 PM ETSep 1, 2026Krepp SarahChief Human Resource OfficerSSaleCommon Stock−274$67.7603−$18.57K117.31K−0.2%SEC10b5-1
Aug 25, 20264:30 PM ETAug 21, 2026Adair JasonChief Business OfficerSSaleCommon Stock−73.63K$69.0908−$5.09M174.61K−29.7%SEC10b5-1
Aug 21, 20264:30 PM ETAug 19 – Aug 20, 2026Rielly-Gauvin KatherineDirectorSSaleCommon Stock−55.18K$74.0719−$4.09M44.64K−55.3%SEC10b5-1
Aug 19, 20266:21 PM ETAug 17 – Aug 19, 2026Saggar RajeevChief Medical OfficerSSaleCommon Stock−79.53K$75.09−$5.97M142.27K−35.9%SEC

The largest institutional positions in LQDA at the end of Q2 2026.

Institutions holding LQDA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.10,788,586$860.17M0.01%+5,299,442+96.5%Added
Farallon Capital Management, L.L.C.8,365,038$666.94M3.90%−291,000−3.4%Reduced
Caligan Partners LP8,118,892$647.32M31.23%00.0%Unchanged
FINDELL CAPITAL MANAGEMENT LLC3,502,112$279.22M46.03%00.0%Unchanged
VANGUARD CAPITAL MANAGEMENT LLC3,139,183$250.29M0.01%+212,238+7.3%Added